Description

IO No. 2 supports Canada’s continued focus on dealing with the significant risk that COVID-19 continues to pose to the health and safety of Canadians.

Resources

Name	Format	Description	Link
Explanatory note on new interim order to advance COVID-19 clinical trials	HTML		https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/interim-order-2-clinical-trials-medical-devices-drugs/explanatory-note.html
Explanatory note on new interim order to advance COVID-19 clinical trials	HTML		https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/arrete-urgence-no-2-cliniques-instruments-medicaux-drogues/note-explanative.html

Tags

Topics

Categories